These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23644835)

  • 1. Impact of transoral incisionless fundoplication (TIF) on subjective and objective GERD indices: a systematic review of the published literature.
    Wendling MR; Melvin WS; Perry KA
    Surg Endosc; 2013 Oct; 27(10):3754-61. PubMed ID: 23644835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis.
    Richter JE; Kumar A; Lipka S; Miladinovic B; Velanovich V
    Gastroenterology; 2018 Apr; 154(5):1298-1308.e7. PubMed ID: 29305934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication.
    Bell RC; Mavrelis PG; Barnes WE; Dargis D; Carter BJ; Hoddinott KM; Sewell RW; Trad KS; DaCosta Gill B; Ihde GM
    J Am Coll Surg; 2012 Dec; 215(6):794-809. PubMed ID: 22939637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis.
    Huang X; Chen S; Zhao H; Zeng X; Lian J; Tseng Y; Chen J
    Surg Endosc; 2017 Mar; 31(3):1032-1044. PubMed ID: 27495332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of transoral incisionless fundoplication for refractory gastroesophageal reflux disease: a systematic review and meta-analysis.
    McCarty TR; Itidiare M; Njei B; Rustagi T
    Endoscopy; 2018 Jul; 50(7):708-725. PubMed ID: 29625507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of transoral incisionless fundoplication (TIF) in the management of gastroesophageal reflux disease (GERD) following peroral endoscopic myotomy (POEM): A pilot, prospective, patient-driven study.
    Ayoub F; Keihanian T; Zabad N; Jawaid S; Patel K; Othman MO
    Saudi J Gastroenterol; 2024 Jul; 30(4):266-271. PubMed ID: 38465439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
    Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
    Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term reported outcomes of transoral incisionless fundoplication: an 8-year cohort study.
    Chimukangara M; Jalilvand AD; Melvin WS; Perry KA
    Surg Endosc; 2019 Apr; 33(4):1304-1309. PubMed ID: 30167944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study.
    Testoni PA; Testoni S; Mazzoleni G; Vailati C; Passaretti S
    Surg Endosc; 2015 Sep; 29(9):2770-80. PubMed ID: 25480624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-year results of a multicenter prospective study of transoral incisionless fundoplication.
    Muls V; Eckardt AJ; Marchese M; Bastens B; Buset M; Devière J; Louis H; Rajan A; Daniel MA; Costamagna G
    Surg Innov; 2013 Aug; 20(4):321-30. PubMed ID: 22968006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transoral Incisionless Fundoplication (TIF 2.0): A Meta-Analysis of Three Randomized, Controlled Clinical Trials.
    Gerson L; Stouch B; Lobonţiu A
    Chirurgia (Bucur); 2018; 113(2):173-184. PubMed ID: 29733015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms.
    Trad KS; Turgeon DG; Deljkich E
    Surg Endosc; 2012 Mar; 26(3):650-60. PubMed ID: 21959689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic Hiatal Hernia Repair Followed by Transoral Incisionless Fundoplication With EsophyX Device (HH + TIF): Efficacy and Safety in Two Community Hospitals.
    Janu P; Shughoury AB; Venkat K; Hurwich D; Galouzis T; Siatras J; Streeter D; Korman K; Mavrelis G; Mavrelis P
    Surg Innov; 2019 Dec; 26(6):675-686. PubMed ID: 31431138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of Laryngopharyngeal Symptoms to Transoral Incisionless Fundoplication in Patients with Refractory Proven Gastroesophageal Reflux.
    Snow GE; Dbouk M; Akst LM; Ihde G; Zarnegar R; Janu P; Murray M; Eskarous H; Sohagia A; Dhar SI; Irene Canto M
    Ann Otol Rhinol Laryngol; 2022 Jun; 131(6):662-670. PubMed ID: 34378427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome.
    Testoni PA; Vailati C; Testoni S; Corsetti M
    Surg Endosc; 2012 May; 26(5):1425-35. PubMed ID: 22170317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of second-generation transoral incisionless fundoplication on atypical GERD symptoms: a systematic review and meta-analysis.
    Haseeb M; Brown JRG; Hayat U; Bay C; Bain PA; Jirapinyo P; Thompson CC
    Gastrointest Endosc; 2023 Mar; 97(3):394-406.e2. PubMed ID: 36402203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transoral incisionless fundoplication for recurrent symptoms after laparoscopic fundoplication.
    Ghosh G; Choi AY; Dbouk M; Greenberg J; Zarnegar R; Murray M; Janu P; Thosani N; Dayyeh BKA; Diehl D; Nguyen NT; Chang KJ; Canto MI; Sharaiha R;
    Surg Endosc; 2023 May; 37(5):3701-3709. PubMed ID: 36650353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transoral incisionless fundoplication offers high patient satisfaction and relief of therapy-resistant typical and atypical symptoms of GERD in community practice.
    Barnes WE; Hoddinott KM; Mundy S; Williams M
    Surg Innov; 2011 Jun; 18(2):119-29. PubMed ID: 21307014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease.
    Bell RC; Freeman KD
    Surg Endosc; 2011 Jun; 25(6):1975-84. PubMed ID: 21140170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.